IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy and safety of incobotulinumtoxinA (Xeomin) in the
treatment of arm tightness (upper limb spasticity) using two different dilutions of
incobotulinumtoxinA (Xeomin).
Phase:
Phase 3
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA